Both recently approved FDA BLAs and the published literature suggest that companies may be considering the use of platform technologies to speed up process development timelines.

• 当前被FDA批准的生物技术产品以及公开发表的生产工艺占有主流优势的是搅拌式生物反应器悬浮培养，工艺设计是流加或灌流培养。